iiinova — where your digital self keeps evolving

ATS Blue Journal @atsblueeditor.bsky.social · 30/09/2026

🚨The October edition of the Blue Journal #AJRCCM is now available with special sections on Interstitial Lung Disease and Cystic Fibrosis. #ILD #CF academic.oup.com/ajrccm/issue... @atscommunity.bsky.social

011

ATS Blue Journal @atsblueeditor.bsky.social · 22/09/2026

Effects of China’s clean heating policy on respiratory symptoms and airway inflammation in adults: a quasi-experimental study in rural Beijing @atscommunity.bsky.social doi.org/10.1093/ajrc...

010

ATS Blue Journal @atsblueeditor.bsky.social · 15/09/2026

Dupilumab in #COPD: a pooled analysis of emergency department visits, hospital admissions, and systemic corticosteroid use. @atscommunity.bsky.social doi.org/10.1093/ajrc...

000

ATS Blue Journal @atsblueeditor.bsky.social · 11/09/2026

The authors identified disease-causing variants in adenylate kinase 8 in patients with primary ciliary dyskinesia. doi.org/10.1093/ajrc... #PCD @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 31/08/2026

The September edition of the Blue Journal is Live! Read the American Journal of Respiratory and Critical Medicine's Special Section on Airway Disease. #AJRCCM academic.oup.com/ajrccm/issue...

010

ATS Blue Journal @atsblueeditor.bsky.social · 31/08/2026

The September edition of the Blue Journal is live! Read the American Journal of Respiratory and Critical Care Medicine's Special Section on Airway Disease. @atscommunity.bsky.social academic.oup.com/ajrccm/issue...

031

ATS Blue Journal @atsblueeditor.bsky.social · 25/08/2026

One Week Left! Apply to become the next Editor-in-Chief of AJRCCM Learn more here: tinyurl.com/42mmsmah @atscommunity.bsky.social

032

ATS Blue Journal @atsblueeditor.bsky.social · 21/08/2026

Spontaneous breathing trials predict inspiratory effort after extubation differently depending on whether oxygen, HFNC, or NIV are applied. doi.org/10.1093/ajrc...

010

ATS Blue Journal @atsblueeditor.bsky.social · 18/08/2026

Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis Not just post-TB: extra-pulmonary tuberculosis cases can have lasting lung impairment after treatment. Expanding post-TB screening is critical doi.org/10.1093/ajrc... @atscommunity.bsky.social

011

ATS Blue Journal @atsblueeditor.bsky.social · 17/08/2026

Subphenotypes of pneumonia defined by pulmonary histopathological features doi.org/10.1093/ajrc... @atscommunity.bsky.social

022

ATS Blue Journal @atsblueeditor.bsky.social · 14/08/2026

Cost-effectiveness of community tuberculosis screening in South Africa Community-based, symptom-agnostic TB screening with chest x-ray followed by confirmatory PCR testing would be cost-effective in South Africa doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 13/08/2026

Single-cell sequencing unveils a profibrotic macrophage and infiltrating monocyte niche in the bronchoalveolar lavage of patients with COPD BAL single-cell RNA sequencing reveals a global dysregulation of the immune landscape in COPD doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 12/08/2026

Deupirfenidone compared with pirfenidone and placebo in idiopathic pulmonary fibrosis (ELEVATE-IPF): a phase 2b randomized placebo-controlled trial Deupirfenidone slowed the rate of FVC decline compared with placebo in IPF doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 11/08/2026

Rocuronium dose and first-attempt intubation success in the critically ill: secondary analysis of two multicenter trials Among adults undergoing intubation with rocuronium, those receiving doses >1.2 mg/kg had higher first-pass success doi.org/10.1093/ajrc... @atscommunity.bsky.social

033

ATS Blue Journal @atsblueeditor.bsky.social · 05/08/2026

Optimizing endpoints in early phase clinical trials of acute respiratory distress syndrome doi.org/10.1093/ajrc... @atscommunity.bsky.social

000

ATS Blue Journal @atsblueeditor.bsky.social · 03/08/2026

Discriminative performance and clinical utility of chronic obstructive pulmonary disease exacerbation categories for predicting future exacerbations doi.org/10.1093/ajrc... @suryapbhatt.bsky.social @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 31/07/2026

The August issue of #AJRCCM is now live! Take a look: academic.oup.com/ajrccm/issue... @atscommunity.bsky.social

042

ATS Blue Journal @atsblueeditor.bsky.social · 31/07/2026

📢 One Month Left! Apply to become the next Editor-in-Chief of AJRCCM Learn more here: tinyurl.com/42mmsmah @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 30/07/2026

BAL-derived extracellular vesicles to test ex vivo for endothelial injury in HIV patients on antiretroviral therapy doi.org/10.1093/ajrc... @atscommunity.bsky.social

011

ATS Blue Journal @atsblueeditor.bsky.social · 29/07/2026

10 mL/kg vs 20 mL/kg fluid bolus in pediatric septic shock: a randomized clinical trial In pediatric septic shock, 10 mL/kg vs 20 mL/kg fluid boluses showed similar early outcomes, with less fluid overload at 24 hours doi.org/10.1093/ajrc... @atscommunity.bsky.social

011

ATS Blue Journal @atsblueeditor.bsky.social · 28/07/2026

Relative contribution of driving pressure and respiratory rate to mortality in ARDS depends on age As age advances, driving pressure becomes relatively more important than respiratory rate to mortality in ARDS doi.org/10.1093/ajrc... @atscommunity.bsky.social

021

ATS Blue Journal @atsblueeditor.bsky.social · 27/07/2026

Safety and antimicrobial efficacy of CSL787, a novel nebulized IgG therapy, in patients with bronchiectasis: results from a randomized phase 1 trial Inhaled immunoglobulin is safe in bronchiectasis and may reduce bacterial load and symptoms doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 24/07/2026

Understanding firefighter qualification under race-neutral spirometry and evolving National Fire Protection Association guidelines doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 24/07/2026

Impact of adopting race-neutral lung function reference equations on firefighter hiring doi.org/10.1093/ajrc... @atscommunity.bluesky

010

ATS Blue Journal @atsblueeditor.bsky.social · 23/07/2026

A large-scale single-cell atlas reveals the pulmonary immune panorama in adult patients with influenza doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 22/07/2026

A statistical model for lung function trajectory and mortality in patients with fibrotic interstitial lung disease doi.org/10.1093/ajrc... @atscommunity.bsky.social

011

ATS Blue Journal @atsblueeditor.bsky.social · 17/07/2026

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 16/07/2026

Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension: an open-label, randomized controlled trial doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 15/07/2026

Mosaic loss of Y chromosome associates with lung function, emphysema, and epigenetic aging doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 14/07/2026

A precision approach to translational research in acute lung injury doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 13/07/2026

Disseminating Research Success Via ATS Journals Stephanie D. Davis, MD, Chair of the ATS Publications Policy Committee, speaks about the work of the ATS Journals 📺Watch the interview here: tinyurl.com/2u73jncu @atscommunity.bsky.social

011

ATS Blue Journal @atsblueeditor.bsky.social · 13/07/2026

Mast cells and endothelial cells mediate interleukin-33 and ST2 responses in distal COPD lungs This study reveals important new insights into the spatial and cellular dynamics of IL-33 and ST2 splice variants in distal COPD lungs doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 10/07/2026

Delirium in the context of the other brain reaction types The authors reframe delirium as an arousal disorder within a spectrum of brain reactions, clarifying phenotypes and reducing imprecision doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 09/07/2026

Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy) Positive phase 3 results showed that the oral pill AD109 improved airway obstruction and oxygenation across OSA disease severity doi.org/10.1093/ajrc... @atscommunity.bsky.social

001

ATS Blue Journal @atsblueeditor.bsky.social · 09/07/2026

A statistical model for lung function trajectory and mortality in patients with fibrotic interstitial lung disease A new model for evaluating treatments in ILD holds promise for improving the accuracy and efficiency of clinical trials doi.org/10.1093/ajrc... @rogerjlewis.bsky.social

011

ATS Blue Journal @atsblueeditor.bsky.social · 06/07/2026

Role of casual contact in drug-resistant tuberculosis transmission: a molecular epidemiology study doi.org/10.1093/ajrc... @emoryrollins.bsky.social @atscommunity.bsky.social

000

ATS Blue Journal @atsblueeditor.bsky.social · 03/07/2026

Mesotype–the missing link between phenotype and endotype in asthma doi.org/10.1093/ajrc... @atscommunity.bsky.social

000

ATS Blue Journal @atsblueeditor.bsky.social · 02/07/2026

US Air Quality Index and respiratory health outcomes: background, knowledge gaps, and research prioritization: an Official American Thoracic Society Research Statement doi.org/10.1093/ajrc... @ats-eoph.bsky.social @atscommunity.bsky.social

000

ATS Blue Journal @atsblueeditor.bsky.social · 01/07/2026

The July issue of #AJRCCM is now live! Take a look: academic.oup.com/ajrccm/issue... @atscommunity.bsky.social

022

ATS Blue Journal @atsblueeditor.bsky.social · 30/06/2026

📢AJRCCM Call for Papers on Critical Care The March 2027 issue of AJRCCM will feature a special section devoted to critical care. Submit your manuscript by October 31, 2026. @atscritcare.bsky.social @atscommunity.bsky.social

054

ATS Blue Journal @atsblueeditor.bsky.social · 24/06/2026

Extracellular vesicle cargo from lipofibroblasts mitigates COPD by alveolar type 2 cell restoration Lipofibroblast EVs restore alveolar type II cells and mitigate COPD, pointing to a new regenerative therapy doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 23/06/2026

Standalone prognostication of idiopathic pulmonary fibrosis using attention-based deep learning From a single baseline CT scan, ORACLE-IPF can predict five-year mortality risk in patients with IPF, advancing established prognostic markers doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 22/06/2026

A new anti-inflammatory treatment for bronchiectasis: a viewpoint on optimal dose selection for DPP1 inhibition in clinical practice doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 19/06/2026

Digital twins for cardiopulmonary medicine: the case for pulmonary arterial hypertension Digital twins combine patient data and AI to personalize care in pulmonary hypertension, paving the way for proactive, predictive medicine doi.org/10.1093/ajrc... @atscommunity

010

ATS Blue Journal @atsblueeditor.bsky.social · 12/06/2026

Toward precision in lung cancer: screening, susceptibility, and therapeutic resistance An introduction to the June issue’s special section on thoracic oncology by our Associate Editor Dr. Patrick Nana-Sinkam doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 11/06/2026

The Blue Journal thanks the Emerging Investigators who contributed to the June issue. Read their biographies here: doi.org/10.1093/ajrc... @atscommunity.bsky.social

010

ATS Blue Journal @atsblueeditor.bsky.social · 11/06/2026

The latest issue of #AJRCCM is now live! Take a look: academic.oup.com/ajrccm/issue... @atscommunity.bsky.social

011

ATS Blue Journal @atsblueeditor.bsky.social · 10/06/2026

Lower airway dysbiosis fuels NETosis in nontuberculous mycobacterial bronchiectasis: rethinking the microbiome-host axis doi.org/10.1093/ajrc... @atscommunity.bsky.social

132

ATS Blue Journal @atsblueeditor.bsky.social · 02/06/2026

📣Apply to Become the Next Editor-in-Chief of AJRCCM Learn more here: tinyurl.com/3uaxwwr6 Please apply before September 1, 2026 @atscommunity.bsky.social

021

ATS Blue Journal @atsblueeditor.bsky.social · 31/05/2026

Streamlined Peer Review for ATS Journals Effective June 1, 2026, authors submitting manuscripts to ATS Journals are only required to list conflicts of interest in a paragraph on the title page of the manuscript. Individual disclosure forms are no longer required. @atscommunity.bsky.social

000